We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Proteinuria After Acute Kidney Injury Predicts Development of Progressive Disease

By LabMedica International staff writers
Posted on 03 Feb 2020
Print article
Image: Kidney specimen from patient who died with acute kidney injury. Image shows marked pallor of the cortex, contrasting to the darker areas of surviving medullary tissue (Photo courtesy of Wikimedia Commons)
Image: Kidney specimen from patient who died with acute kidney injury. Image shows marked pallor of the cortex, contrasting to the darker areas of surviving medullary tissue (Photo courtesy of Wikimedia Commons)
A report has suggested that testing recently hospitalized kidney patients for proteinuria could be a way to identify those at higher risk for developing progressive kidney disease, which could require dialysis or surgery.

Clinicians agree that among patients who had acute kidney injury (AKI) during hospitalization, there is a need to improve risk prediction so that those at highest risk for subsequent loss of kidney function are identified for appropriate follow-up.

To this end, investigators at the University of California, San Francisco (USA) and colleagues at several other institutions worked with participants in The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. This was a multicenter prospective cohort study including four clinical centers in North America that included 1538 patients enrolled three months after hospital discharge between December 2009 and February 2015. Of the 1538 participants, 769 (50%) had AKI during hospitalization.

To detect proteinuria, the investigators measured urine albumin-to-creatinine ratio (ACR) three months after hospital discharge. The mean age of the patients was 65 years, and the median urine ACR was 15 milligrams per gram. Overall, 547 (37%) of the participants were women and 195 (13%) were black.

Results revealed that after a median follow-up of 4.7 years, 138 (9%) participants had kidney disease progression. Higher post-AKI urine ACR level was associated with increased risk of kidney disease progression, and urine ACR measurement was a strong discriminator for future kidney disease progression. The performance of urine ACR was stronger in patients who had had AKI than in those who had not.

"There should be much more emphasis on the testing of proteinuria after AKI to identify high-risk patients," said first author Dr. Chi-yuan Hsu, professor of nephrology at the University of California, San Francisco. "This simple test carries important prognostic information not conveyed by serum creatinine. Too many providers rely on serum creatinine alone to assess the health of the kidneys, but they should not be falsely assured by the latter. Having a more complete picture of kidney health is necessary for proper clinical decision-making."

"Most patients with acute kidney injury are unaware of their condition, lack understanding of its natural history or predisposing factors, and desire more information," said Dr. Hsu. "However, few discharge communications currently provided to these patients explain the condition or provide recommendations for care, which is needed throughout the care continuum."

The AKI study was published in the January 27, 2020, online edition of the journal JAMA Internal Medicine.

Related Links:
University of California, San Francisco

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more